CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $1.7B, above the global median of $1.18B
- FinancialsAltman Z-Score 2.39: grey zone
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.70BUSDvs all stocks (USD)
Trailing P/E
16.12xRevenue (TTM)
978.38MUSDvs all stocks (USD)
Profit Margin
11.07%Beta
0.4500xvs all stocks
52-Week Change
-19.50%vs all stocks
Market Capitalization
1.70BUSDvs all stocks (USD)
Enterprise Value
1.83BUSDvs all stocks (USD)
Trailing P/E
16.12xForward P/E
7.06xPEG Ratio
0.0828xPrice to Sales (TTM)
1.74xPrice to Book (MRQ)
2.66xEnterprise to Revenue
1.88xEnterprise to EBITDA
8.76xGross Margin
62.35%Profit Margin
11.07%Operating Margin
14.97%Return on Assets (TTM)
5.45%Return on Equity (TTM)
20.46%Revenue (TTM)
978.38MUSDvs all stocks (USD)
Revenue per Share (TTM)
47.24USDUpdated Sep 26, 2026Quarterly Revenue Growth
25.90%Gross Profit (TTM)
590.98MUSDvs all stocks (USD)
EBITDA (TTM)
215.19MUSDvs all stocks (USD)
Net Income (TTM)
99.60MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
189.10%Operating Cash Flow (TTM)
189.47MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
132.21MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Sep 26, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%Revenue
883.37MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
341.31MUSDFY2025 · Dec 31, 2025Gross Profit
542.06MUSDFY2025 · Dec 31, 2025Operating Income
81.23MUSDvs all stocks (USD)
Pre-tax Income
95.79MUSDFY2025 · Dec 31, 2025Income Tax Expense
17.45MUSDFY2025 · Dec 31, 2025Net Income
78.34MUSDFY2025 · Dec 31, 2025EBIT
115.85MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
174.58MUSDFY2025 · Dec 31, 2025Research & Development
51.66MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
317.75MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
20.06MUSDFY2025 · Dec 31, 2025EPS (Basic)
3.50USDFY2025 · Dec 31, 2025EPS (Diluted)
3.32USDFY2025 · Dec 31, 2025Basic Shares Outstanding
20.05MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
20.05MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
78.34MUSDFY2025 · Dec 31, 2025Preferred Stock Dividends
6.96MUSDFY2025 · Dec 31, 2025Operating Cash Flow
139.39MUSDFY2025 · Dec 31, 2025Free Cash Flow
125.55MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
285.62MUSDFY2025 · Dec 31, 2025Income Tax Paid
17.67MUSDFY2025 · Dec 31, 2025Interest Paid
26.93MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
78.34MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
91.42MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
14.24MUSDFY2025 · Dec 31, 2025Stock-based Compensation
37.93MUSDFY2025 · Dec 31, 2025Other Non-cash Items
-27.90MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-58.53MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
15.16MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-11.26MUSDFY2025 · Dec 31, 2025Capital Expenditures
-13.84MUSDFY2025 · Dec 31, 2025Net Intangibles (CF)
-20.49MUSDFY2025 · Dec 31, 2025Net Acquisitions
0.00USDFY2025 · Dec 31, 2025Net Investing Cash Flow
-13.84MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025Long-term Debt Payments
-10.16MUSDFY2025 · Dec 31, 2025Common Stock Repurchase
-12.21MUSDFY2025 · Dec 31, 2025Common Dividends Paid
-1.16MUSDFY2025 · Dec 31, 2025Other Financing Charges
-26.00KUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-23.55MUSDFY2025 · Dec 31, 2025Shares Outstanding
22.97MSharesUpdated Sep 26, 2026Float Shares
19.66MSharesUpdated Sep 26, 2026Shares Short
2.49MSharesUpdated Sep 26, 2026Short Ratio
7.01daysvs all stocks
Short % of Shares Outstanding
13.21%vs all stocks
% Held by Insiders
5.42%vs all stocks
% Held by Institutions
107.07%vs all stocks
Total Cash (MRQ)
376.96MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
17.59USDUpdated Sep 26, 2026Total Debt (MRQ)
626.03MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
1.05xCurrent Ratio (MRQ)
2.91xBook Value per Share (MRQ)
27.87USDUpdated Sep 26, 2026Total Assets
1.44BUSDvs all stocks (USD)
Total Current Assets
753.12MUSDFY2025 · Dec 31, 2025Total Liabilities
899.65MUSDFY2025 · Dec 31, 2025Total Non-current Assets
687.26MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
621.54MUSDFY2025 · Dec 31, 2025Total Current Liabilities
278.11MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
285.58MUSDFY2025 · Dec 31, 2025Other Short-term Investments
9.13MUSDFY2025 · Dec 31, 2025Accounts Receivable
281.08MUSDFY2025 · Dec 31, 2025Inventory
143.07MUSDFY2025 · Dec 31, 2025Accounts Payable
62.58MUSDFY2025 · Dec 31, 2025Short-term Debt
17.27MUSDFY2025 · Dec 31, 2025Other Current Liabilities
167.00KUSDFY2025 · Dec 31, 2025Long-term Debt
599.77MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
21.77MUSDFY2025 · Dec 31, 2025Common Stock (Book)
3.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-23.10MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
540.72MUSDvs all stocks (USD)
Treasury Stock
33.25MUSDFY2025 · Dec 31, 202552-Week Low
69.58USDUpdated Sep 26, 202652-Week High
97.00USDUpdated Sep 26, 202652-Week Change
-19.50%vs all stocks
Beta
0.4500xvs all stocks
50-Day MA
75.85USDUpdated Sep 26, 2026200-Day MA
78.73USDUpdated Sep 26, 2026Avg 10-Day Volume
512.86KSharesUpdated Sep 26, 2026Avg 30-Day Volume
400.01KSharesUpdated Sep 26, 2026Diluted EPS (TTM)
4.59USDUpdated Sep 26, 2026Other Income / Expense
34.62MUSDFY2025 · Dec 31, 2025Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.39: grey zoneSignificant
Altman Z-Score: 2.39
High earnings qualityNotable
Earnings Quality Score: 0.94
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $1.7B, above the global median of $1.18BNotable
Market cap (USD): 1,699,806,048Global Median: 1,180,223,658.953
Revenue is $978.38M, above the global median of $548.88MNotable
Revenue (USD): 978,379,008Global Median: 548,883,780.48
Levered free cash flow is $132.21M, above the global median of $18.73MNotable
Levered free cash flow (USD): 132,205,752Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Yifan Pharmaceutical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Green Thumb Industries Inc.
Tier 1ProductionApproval-Gated PipelineFlowRule
Olix Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Shenzhen Edge Medical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Jiangxi Fushine Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Shanghai Shyndec Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Beijing Aosaikang Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Alembic Pharmaceuticals Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Absci Corporation
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Hugel Inc.
Tier 1ProductionApproval-Gated PipelineRule